Laboratory Corporation of America Holdings (LH)
- Previous Close
198.35 - Open
197.08 - Bid 190.00 x 1200
- Ask 202.99 x 800
- Day's Range
197.01 - 200.15 - 52 Week Range
179.59 - 234.09 - Volume
913,477 - Avg. Volume
781,301 - Market Cap (intraday)
16.725B - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
42.94 - EPS (TTM)
4.62 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield 2.88 (1.45%)
- Ex-Dividend Date May 28, 2024
- 1y Target Est
242.20
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
www.labcorp.com67,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: LH
Performance Overview: LH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LH
Valuation Measures
Market Cap
16.73B
Enterprise Value
22.59B
Trailing P/E
42.85
Forward P/E
13.37
PEG Ratio (5yr expected)
0.47
Price/Sales (ttm)
1.48
Price/Book (mrq)
2.10
Enterprise Value/Revenue
1.95
Enterprise Value/EBITDA
16.73
Financial Highlights
Profitability and Income Statement
Profit Margin
3.52%
Return on Assets (ttm)
3.75%
Return on Equity (ttm)
4.37%
Revenue (ttm)
12.3B
Net Income Avi to Common (ttm)
399.2M
Diluted EPS (ttm)
4.62
Balance Sheet and Cash Flow
Total Cash (mrq)
99.3M
Total Debt/Equity (mrq)
74.84%
Levered Free Cash Flow (ttm)
1.05B
Research Analysis: LH
Company Insights: LH
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: LH
Analyst Report: Laboratory Corporation of America Holdings
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
RatingPrice TargetAnalyst Report: Laboratory Corporation of America Holdings
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
RatingPrice TargetWeekly Stock List
Argus has published its latest Portfolio Selector, which features its popular Focus List. Each month, Director of Research Jim Kelleher, CFA, surveys the team of Argus Research industry analysts for their timeliest recommendations out of the company's fundamental universe of approximately 500 stocks. The Focus List typically includes 30 stocks: turnover is high, as Jim typically adds three or four new stocks per month. Below are the latest additions, all of which are rated BUY at Argus.
Solid 1Q Leads into 2Q Uncertainty
The Portfolio Selector features the Argus Focus List, a group of 30 "best idea" stocks generated and regularly updated by Argus' analysts and investment policy committee. It also includes the director of research’s monthly investment strategy column, stock recommendations and sector picks, economic forecasts, and an asset allocation model. This month, the Focus List additions are Laboratory Corp. Of America Hl (LH); Micron Technology Inc. (MU); Oracle Corp. (ORCL); Invesco Ltd (IVZ) and the Focus List deletions are Advanced Micro Devices Inc. (AMD); American Express Co. (AXP); Crowdstrike Holdings Inc (CRWD); Unitedhealth Group Inc (UNH).